Testing who benefits most from mepolizumab for nasal polyps
Treatments studied
Part of Infections clinical trials.
This study looks at why some people with severe chronic nasal polyps respond better to mepolizumab. It may help doctors predict who will benefit from the medicine, and who may need a different plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have nasal polyps on both sides (confirmed by nasal exam and/or past CT scan)
- You had nasal polyp surgery at least once in the past 10 years
- Your symptoms are severe and match a need for surgery (blocked nose and other symptoms for at least 12 weeks)
- You’ve been using an intranasal steroid (nose spray or steroid rinses) for at least 4 weeks
- You have at least two common long-lasting sinus/nasal symptoms (like blockage, discharge, facial pain/pressure, or worse sense of smell)
- You don’t have major conditions that can change eligibility (such as cystic fibrosis or certain rare immune diseases)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and other measures (biomarkers) to understand how well mepolizumab helps people with nasal polyps, with or without asthma. It aims to find response clues that could help personalize treatment in the future.
This study looks at how “biologic” medicines work in real-life care for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP). It may help confirm which patients benefit and how treatment is used in everyday practice.
This trial tests if patients with chronic sinusitis and nasal polyps can safely reduce how often they take their biologic medication (dupilumab or mepolizumab) after their disease has been partly controlled for at least a year.
This study looks at different “immune inflammation patterns” in people with asthma and/or nasal polyps. It may help researchers better tailor future treatments by figuring out which patterns go with which symptoms.
This trial tests a new injection (SHR-1905) for people with chronic sinusitis and nasal polyps who still have symptoms despite using standard nasal spray treatments. It aims to see if the drug can reduce polyp size and improve symptoms.
This study tests whether tezepelumab, a new injectable medicine, can help reduce nasal polyps and improve symptoms like nasal congestion, loss of smell, and sleep problems. You would receive the study drug while continuing your current nasal steroid spray, and your doctors would track how your symptoms change.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.